Lorlatinib T3061
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
PF-06463922 is an orally available, ATP-competitive inhibitor of the receptor tyrosine kinases, anaplastic lymphoma kinase (ALK) and C-ros oncogene 1 (Ros1), with potential antineoplastic activity.
CAS nr:
1454846-35-5
Purity:
98%
Molecular Weight:
406,41
SMILES:
c1cc(cc2c1C(=O)N(C)Cc1c(c3cc(O[C@@H]2C)c(nc3)N)c(n(n1)C)C#N)F
Formula:
C21H19FN6O2
Pathway:
Tyrosine Kinase/Adaptors,Angiogenesis,Immunology/Inflammation,Apoptosis,Tyrosine Kinase/Adaptors
Target:
ALK,ALK,ROS,Apoptosis,Tyrosine Kinases
